Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG: 9989)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.880
+0.050 (1.31%)
Jan 27, 2025, 11:49 AM HKT
43.70%
Market Cap 14.39B
Revenue (ttm) 6.04B
Net Income (ttm) -162.06M
Shares Out n/a
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 414,000
Average Volume 405,625
Open 3.810
Previous Close 3.830
Day's Range 3.800 - 3.880
52-Week Range 2.390 - 5.920
Beta 0.51
RSI 52.19
Earnings Date Mar 29, 2025

About Shenzhen Hepalink Pharmaceutical Group

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium A... [Read more]

Sector Healthcare
Founded 1998
Employees 2,080
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9989
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.